IGC Pharma, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
IGC Pharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2023.
  • IGC Pharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $402K, a 12.6% increase year-over-year.
  • IGC Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.77M, a 37.6% decline from 2022.
  • IGC Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.84M, a 29.4% increase from 2021.
  • IGC Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.2M, a 234% increase from 2020.
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.77M -$1.07M -37.6% Apr 1, 2023 Mar 31, 2024 10-K 2024-06-24
2022 $2.84M +$646K +29.4% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-24
2021 $2.2M +$1.54M +234% Apr 1, 2021 Mar 31, 2022 10-K 2023-07-07
2020 $658K -$112K -14.5% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-23
2019 $770K +$160K +26.2% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-14
2018 $610K +$34K +5.9% Apr 1, 2018 Mar 31, 2019 10-K 2020-07-13
2017 $576K Apr 1, 2017 Mar 31, 2018 10-K 2019-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.